We found that AML cells induce in osteogenesis-committed BMSCs a reduction in the expression of HSC-regulating genes, such as VCAM1, BMP4, and ANGPT1, that could affect HSC retention and quiescence and deplete the normal HSC pool (25–27). This evidence concerns the gene ANGPT1 and acute myeloid leukemia.